Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 162 studies whose lead sponsor is Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. 71 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Keep track of what changes. Save the Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 162. Browse all 162 →
- Iparomlimab and Tuvonralimab With With Cetuximab in Resectable OSCCRecruitingNCT07882888Phase 2
- Hearing Intervention Effects on Brain and Language Development in Children With Bilateral Mild Hearing LossNot yet recruitingNCT07774728Not applicable
- Abiraterone With Dalpiciclib in Salivary Gland CarcinomaRecruitingNCT07815522Phase 2
- Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell CarcinomaNot yet recruitingNCT07745803
- Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell HistiocytosisNot yet recruitingNCT07728201Phase 2
- Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and DermatitisRecruitingNCT07029178Phase 2
- Efficacy of Lymphatic-Venous Anastomosis Plus Donepezil Versus Donepezil Alone for Alzheimer's DiseaseNot yet recruitingNCT07680660Not applicable
- Acupuncture Versus Sham Acupuncture for TinnitusNot yet recruitingNCT07700069Not applicable
- Camrelizumab With Famitinib for Patients With Rare Head and Neck MalignanciesRecruitingNCT07662681Phase 1/2
- CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal MelanomaNot yet recruitingNCT07662694
- Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT07662746Phase 2
- Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCRecruitingNCT07088211Phase 2
- Iparomlimab and Tuvonralimab in HNSCCRecruitingNCT07090317Phase 2
- Hidden Hearing Loss in Older AdultsRecruitingNCT07646119
- Comparison of Accuracy of Full-arch Implant Digital and Conventional Impressions.Enrolling by invitationNCT07190820Not applicable
- Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell CarcinomaRecruitingNCT07632339Phase 2
- Hearing and Brain Development Cohort in Children and AdolescentsRecruitingNCT07625462
- Accuracy of Immediate Implant Placement Using Robotic System Versus Dynamic Navigation System in Anterior Maxillae: A Random Controlled Clinical TrialNot yet recruitingNCT06895915Not applicable
- Personalized Two-stage Regional Citrate Anticoagulation for CRRT in Patients With Citrate Metabolism ImpairmentNot yet recruitingNCT07579663Not applicable
- ADC and SBRT for Recurrent/Metastatic Salivary Gland CarcinomaNot yet recruitingNCT07579598Phase 2
- Surgical Robot or Static Guide for Dental Implant PlacementNot yet recruitingNCT07577245Not applicable
- Preservation of Venous Valvular Function After PMT for Acute DVTEnrolling by invitationNCT05588284Not applicable
- Stents Post-dilation With DCB or POBA in Femoropopliteal ArteriesRecruitingNCT03791970Not applicable
- Diagnostic Accuracy of Oral Images, OPGs, Biomarkers and Questionnaires vs. Clinical Assessment for Periodontal Disease (PostNCT07164573)RecruitingNCT07406867
- Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT07535567Phase 2/3
- Is Professional Tooth Cleaning Necessary for Managing Gingivitis (Gingival Inflammation) if Subjects Use Intelligent Toothbrushes?RecruitingNCT07549347Not applicable
- Discovery and Validation of Periodontitis BiomarkersRecruitingNCT07293481
- Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell CarcinomaRecruitingNCT07445048Phase 3
- Impact of Day 2 Versus Day 3 Fresh Embryo Transfer on Live Birth Rate in Poor-Prognosis PatientsNot yet recruitingNCT07533695Not applicable
- Development and Validation of the Periodontal Map Derived From IOS and CBCT Registration for Diagnosis and Treatment Planning in Moderate-to-severe PeriodontitisNot yet recruitingNCT07505251
- The Impact of Assisted Hatching on Pregnancy Outcomes After Vitrified-Warmed Embryo Transfer in Advanced-age PatientsNot yet recruitingNCT07490561Not applicable
- Resection and Defect Repair of Oral Cancer Aided by Mixed Reality TechnologyNot yet recruitingNCT07466810Not applicable
- Comparing Cleaning Tools for Full-Arch Implant-Supported Fixed ProsthesesRecruitingNCT07474493Not applicable
- A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)Not yet recruitingNCT07353073Phase 2
- AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal ErythemaRecruitingNCT07349095Not applicable
- De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT07320690Phase 3
- Diagnostic Accuracy of Oral Images, OPGs, and Questionnaires vs. Clinical Assessment for Periodontal DiseaseNot yet recruitingNCT07164573
- The Effect of Stromal Vascular Fraction Transplantation on the Regeneration of Expanded SkinNot yet recruitingNCT07114692Not applicable
- Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCCRecruitingNCT06935188Phase 2
- A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated OphthalmopathyRecruitingNCT06927375Phase 4
- Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCCRecruitingNCT06876844Phase 2
- Influence of Healing Time on the Outcomes of Alveolar Ridge Preservation in Periodontally Compromised Extraction SocketsRecruitingNCT06654141Not applicable
- Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell CarcinomaRecruitingNCT06470217Phase 2
- Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated AmeloblastomaNot yet recruitingNCT06819605Phase 2/3
- Uremic Toxins and Outcomes in Chronic Kidney DiseaseRecruitingNCT03711617
- Clinical Study of Neoadjuvant Targeted Therapy for AmeloblastomaRecruitingNCT06653517Phase 2
- Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)Not yet recruitingNCT06647563Phase 3
- The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and RadiotherapyRecruitingNCT06503276Phase 2
- Periodontal Initial Treatment Combined With Glucocorticoid Therapy for Erosive Oral Lichen PlanusNot yet recruitingNCT06498180Not applicable
- A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE)RecruitingNCT06379230